Description
The Fc fragment of an antibody is closely associated with ADCC, ADCP, CDC, and the half-life of drugs. ACROBiosystems has launched a comprehensive range of Fc receptor proteins, including FcγRI, FcγRIIA, FcγRIIB, FcγRIIB/C, FcγRIII, FcγRIIIA, FcγRIIIB, Fc gamma RIIIB / CD16b, FcRn, FceR and FcaR to contribute to the evaluation and optimization of drug efficacy and safety, thereby aiding in the development of better antibody therapeutics during the stages of antibody drug discovery and quality control.